A bench of Chief Justice G Rohini and Justice Rajiv Sahai Endlaw set aside the National Pharmaceutical Pricing Authority (NPPA's) orders capping prices of male contraceptive devices, saying it exceeded the powers conferred upon it under the Drug Price Control Order (DPCO) of 2013.
"We are of the view that NPPA exceeded the powers conferred by DPCO-2013 while fixing the ceiling price for condoms. The language of para 4 (of DPCO 2013) is unambiguous and makes clear the legislative intent that the ceiling price can be fixed only for scheduled formulations of specified strengths and dosages as specified under the First Schedule.
"Consequently, fixation of the ceiling price for condoms under DPCO-2013 is impermissible under law. Accordingly, we declare that the orders of NPPA dated November 5, 2013, and July 10, 2014, are illegal and unsustainable. In the result, both the said orders are hereby set aside," the court said.
It was also of the view that inclusion of condoms in DPCO 2013 was not ultra vires of the provisions of the Essential Commodities Act, saying it was a "medicine as well as a substance for use of human beings for mitigation or prevention of a disease or disorder" as provided under the Drugs and Cosmetics Act, 1940.
Pharma companies Reckitt Benckiser and J K Ansell Ltd (JKAL) in their pleas challenged the two NPPA orders and contended that condoms were not drugs, but were rather devices and thus, cannot be included in DPCO 2013.
NPPA by its November 5, 2013 order had initially capped condom prices at Rs 6.56 per unit and this was later increased to Rs 8.04 by its July 10, 2014, notification.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
